UBS analyst Weston Bloomer raised the firm’s price target on Arthur J. Gallagher to $220 from $212 and keeps a Neutral rating on the shares. Management’s commentary around the macro backdrop at its investor day event was in line and the firm was encouraged by the company’s updates around organic growth in both Brokerage and Risk Management, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on AJG:
- Arthur J. Gallagher to host virtual investor meeting
- Arthur J. Gallagher & Co. Acquires Bernard Benefits and Bernard Healthcare Financial Planning
- Arthur J. Gallagher & Co. Acquires Insurance by Ken Brown, Inc.
- Arthur J. Gallagher & Co. Acquires Allied Risk Management
- Fly Insider: Kinnate Biopharma, Arrowhead among week’s notable insider trades